Evolution of multiple myeloma treatment practices in Europe from 2014 to 2016

Br J Haematol. 2019 Jun;185(5):981-984. doi: 10.1111/bjh.15680. Epub 2018 Nov 22.

Authors

Marc S Raab¹, Leah Fink², Paul Schoen³, Sebastian Gonzalez-McQuire³, Alain Flinois², Michele Cavo⁴, Maria-Victoria Mateos⁵, Kwee Yong⁶

Affiliations

¹ Department of Internal Medicine V, University of Heidelberg, Heidelberg, Germany.
² Kantar Health, Montrouge, France.
³ Amgen (Europe) GmbH, Rotkreuz, Switzerland.
⁴ "Seragnoli" Institute of Haematology and Medical Oncology, Bologna University School of Medicine, Bologna, Italy.
⁵ Haematology Service, University Hospital, Salamanca, Salamanca, Spain.
⁶ Department of Haematology, University College London, London, UK.

PMID: 30467828
DOI: 10.1111/bjh.15680

No abstract available

Keywords: European chart review; multiple myeloma; observational; practice patterns; real-world.

Publication types

Historical Article

MeSH terms

Europe
Female
History, 21st Century
Humans
Male
Multiple Myeloma / therapy*